NCT07262164 2026-03-25A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid TumorsVirogin Biotech Ltd.Phase 1 Recruiting30 enrolled